Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.25 USD | 0.00% | -17.19% | +10.99% |
20/02 | Sigyn Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Sigyn Therapeutics, Inc. Appoints Jerry Deciccio as Chief Financial Officer | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 6.08M 507M |
---|---|---|---|---|---|
Net income 2022 | -2M -167M | Net income 2023 | -4M -334M | EV / Sales 2022 | - |
Net Debt 2022 | 1.87M 156M | Net Debt 2023 | 2.47M 206M | EV / Sales 2023 | - |
P/E ratio 2022 |
-2.13
x | P/E ratio 2023 |
-1.25
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
1 week | -17.19% | ||
Current month | -12.50% | ||
1 month | -4.55% | ||
3 months | +75.00% | ||
6 months | -6.91% | ||
Current year | +10.99% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Roberts
FOU | Founder | 71 | 19/19/19 |
James Joyce
CEO | Chief Executive Officer | 62 | 19/19/19 |
Jerry DeCiccio
DFI | Director of Finance/CFO | 67 | 12/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
James Joyce
CEO | Chief Executive Officer | 62 | 19/19/19 |
James W. Dorst
BRD | Director/Board Member | 69 | 10/22/10 |
Richa Nand
BRD | Director/Board Member | 50 | 10/22/10 |
Date | Price | Change | Volume |
---|---|---|---|
03/24/03 | 5.25 | 0.00% | 300 |
02/24/02 | 5.25 | -4.55% | 200 |
01/24/01 | 5.5 | -8.33% | 400 |
30/24/30 | 6 | -5.36% | 290 |
Delayed Quote OTC Markets, May 03, 2024 at 11:11 pm IST
More quotesChiffre d''affaires - Rate of surprise
- Stock Market
- Equities
- SIGY Stock